HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-xiao Zhang Selected Research

Pathologic Constriction (Stenosis)

11/2006[Safety and efficacy comparison between rapamycin-eluting stent with biodegradable polymer or permanent polymer in patients with coronary artery disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-xiao Zhang Research Topics

Disease

2Hemorrhage
12/2011 - 09/2011
1Acute Coronary Syndrome
12/2011
1Thrombosis (Thrombus)
12/2011
1Myocardial Infarction
12/2011
1Thrombocytopenia (Thrombopenia)
12/2011
1Atrial Fibrillation
09/2011
1Cardiovascular Diseases (Cardiovascular Disease)
11/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2006
1Pathologic Constriction (Stenosis)
11/2006

Drug/Important Bio-Agent (IBA)

1Tirofiban (Aggrastat)FDA Link
12/2011
1Cytochrome P-450 CYP2C9IBA
09/2011
1Warfarin (Coumadin)FDA LinkGeneric
09/2011
1Phenobarbital (Luminal)FDA Link
11/2006
1Sirolimus (Rapamycin)FDA Link
11/2006
1omega-Chloroacetophenone (Mace)IBA
11/2006
1PolymersIBA
11/2006

Therapy/Procedure

2Stents
12/2011 - 11/2006
1Percutaneous Coronary Intervention
12/2011